GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Bio Techne Corporation
Bio-Techne supplies reagents, tools, and proteins for biomedical research. Its share price reflects the volume of funding for science and R&D in the pharmaceutical industry. It has a history of stable growth based on the critical importance of its products for the development of new drugs.
Share prices of companies in the market segment - Diagnostic medical equipment
Bio-Techne operates in the biomedical research reagent and instrument manufacturing segment. We classify it as part of the Diagnostic Medical Equipment sector. The graph below shows the dynamics of this segment, which is dependent on the level of research and R&D funding.
Broad Market Index - GURU.Markets
Bio-Techne is a life sciences company that produces and sells high-quality proteins, antibodies, and other reagents for scientific research and diagnostics. Its scale makes it part of the GURU.Markets index. The chart below compares its performance to the overall market.
Change in the price of a company, segment, and market as a whole per day
TECH - Daily change in the company's share price Bio Techne Corporation
For Bio-Techne, a research reagent manufacturer, daily price changes are a measure of volatility related to biotech news and research funding. This metric is a key component of more complex analytical models on System.GURU.Markets that assess the dynamics of the life sciences sector.
Daily change in the price of a set of shares in a market segment - Diagnostic medical equipment
Bio-Techne Corporation is a supplier of reagents and instruments for biomedical research. This chart shows the average daily volatility of the sector. Comparing this to TECH, whose business depends on stable R&D budgets, helps understand its resilience to general market fluctuations.
Daily change in the price of a broad market stock, index - GURU.Markets
Bio-Techne is a diversified company supplying reagents, instruments, and services for biomedical research. Its business serves as a barometer of global scientific activity. The chart below shows general market fluctuations, which can be used to assess Bio-Techne's stability.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Bio Techne Corporation
Bio-Techne is a key supplier of reagents and instruments for biomedical research. Its annual growth rate serves as a barometer of R&D investment in the pharmaceutical and biotech industries. The chart below tells the story of this knowledge-intensive business, which benefits from overall scientific progress.
Annual dynamics of market capitalization of the market segment - Diagnostic medical equipment
Bio-Techne Corporation is a supplier of high-quality reagents, instruments, and services for biotech research and clinical diagnostics. Its products are the building blocks of scientific discovery. The chart shows how its key role in R&D ensures stable growth that outpaces the industry.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Bio-Techne, a supplier of reagents for scientific research, enjoys a stable and predictable business. R&D budgets in the pharmaceutical and biotech industries are largely unaffected by economic cycles. The company's stock price often appears like a safe haven, demonstrating sustainable growth based on long-term scientific developments rather than short-term market fluctuations.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Bio Techne Corporation
Bio-Techne, a manufacturer of reagents and instruments for biomedical research, depends on its R&D budgets for its business. The monthly fluctuations in the chart reflect demand from pharmaceutical and biotech companies, which remains stable due to the ongoing need for scientific research.
Monthly dynamics of market capitalization of the market segment - Diagnostic medical equipment
This chart reflects the dynamics of the life sciences sector. For Bio-Techne, a leader in reagent and instrument production, this provides context. Its steady growth reflects continued demand from research laboratories and pharmaceutical companies.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Bio-Techne supplies reagents, instruments, and services for biomedical research. They are the "shovel suppliers" during the biotech gold rush. The chart below shows the overall market sentiment. Bio-Techne's performance depends on the level of scientific funding, making it relatively stable, but not immune to general market downturns.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Bio Techne Corporation
Shares of Bio-Techne, a developer of reagents for biomedical research, respond to scientific news. Weekly performance reflects reports of research breakthroughs, regulatory approvals, and changes in science and healthcare funding.
Weekly dynamics of market capitalization of the market segment - Diagnostic medical equipment
Bio-Techne operates in the biomedical research sector, where overall trends are driven by the volume of research funding and R&D budgets of pharmaceutical companies. News about research breakthroughs or changes in government support impact all suppliers. The chart allows you to compare whether Bio-Techne is ahead of the curve or moving with its sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Bio-Techne, as a healthcare company, can demonstrate defensive qualities while moving out of sync with the broader market. Demand for its reagents is less dependent on economic cycles than that of industrial giants. The chart will help assess whether Bio-Techne truly is a safe haven during general market storms or whether its shares are simply following the general trend.
Market capitalization of the company, segment and market as a whole
TECH - Market capitalization of the company Bio Techne Corporation
Bio-Techne's market capitalization is a monetary expression of progress in the life sciences. The chart shows how the market evaluates demand for reagents and tools for biotech and pharmaceutical research. Its growth reflects investors' belief that the company will be at the forefront of new scientific discoveries and the development of innovative drugs.
TECH - Share of the company's market capitalization Bio Techne Corporation within the market segment - Diagnostic medical equipment
Bio-Techne is a supplier of reagents and instruments for biomedical research. The company's share of the diagnostic equipment segment market capitalization reflects its weight in the scientific and pharmaceutical industries. The chart below illustrates its competitive position and ability to grow value through innovation and acquisitions.
Market capitalization of the market segment - Diagnostic medical equipment
Bio-Techne produces reagents and tools for biotech research. The chart below shows the total market value of diagnostic equipment. This represents the market capitalization of an industry at the forefront of disease control and the development of personalized medicine.
Market capitalization of all companies included in a broad market index - GURU.Markets
Bio-Techne supplies reagents and tools for biotech research. The company's market capitalization reflects the value of its contribution to scientific progress and the development of new drugs. Compared to the global market, its value reflects the share of the economy devoted to fundamental science, which forms the basis for future medical breakthroughs.
Book value capitalization of the company, segment and market as a whole
TECH - Book value capitalization of the company Bio Techne Corporation
Bio-Techne's book value is scientific capital. It consists of laboratories, sophisticated equipment for producing reagents and diagnostic instruments, and patents for unique biotechnologies. The chart below shows how the company has grown its material and intellectual foundation, becoming a key supplier to global science and medicine.
TECH - Share of the company's book capitalization Bio Techne Corporation within the market segment - Diagnostic medical equipment
Bio-Techne relies on cutting-edge laboratories and manufacturing centers to create reagents and instruments. These scientific complexes are its physical foundation. The chart below shows the proportion of the entire laboratory and manufacturing infrastructure in the biotechnology sector that this company controls.
Market segment balance sheet capitalization - Diagnostic medical equipment
The medical equipment sector, whose total book value is shown in the chart, requires significant investment in production and R&D. Against this backdrop, Bio-Techne appears to be a capital-intensive player. The creation of reagents and scientific instruments requires in-house laboratories and production facilities, which contributes to the company's substantial book value.
Book value of all companies included in the broad market index - GURU.Markets
Bio-Techne owns laboratories and production facilities where reagents and tools for scientific discoveries are created. Their balance sheet provides the physical foundation for thousands of biotech research projects. A glance at the market's total assets chart reveals the entire global "scientific infrastructure" and the extent to which this company has built it.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Bio Techne Corporation
Bio-Techne's balance sheet is the value of its laboratories and reagent production facilities. Its market value is a measure of its reputation and role as a "bullet supplier" for the army of biotech research. The graph shows how much its ability to supply thousands of scientists worldwide is worth more than the cost of the production lines themselves.
Market to book capitalization ratio in a market segment - Diagnostic medical equipment
Bio-Techne supplies reagents and tools for biotech research. This chart shows the market premium placed on its scientific potential and patent portfolio compared to physical laboratories and equipment. This gap between the two sectors reflects expectations for its future discoveries.
Market to book capitalization ratio for the market as a whole
Bio-Techne Corporation develops and manufactures reagents and tools for biotech research and clinical diagnostics. The company's core value lies in its intellectual property and scientific developments. This chart helps explain why companies in science-intensive industries often have high market valuations relative to their tangible assets, compared to the market as a whole.
Debts of the company, segment and market as a whole
TECH - Company debts Bio Techne Corporation
Bio-Techne, a biotech company, uses debt to fund research and acquire promising companies. This chart illustrates how debt capital accelerates the development of new diagnostic tools and reagents. In this knowledge-intensive industry, debt is a way to bring innovative products to market faster and expand the portfolio.
Market segment debts - Diagnostic medical equipment
Bio-Techne Corporation supplies the scientific community and clinical diagnostics with reagents and tools. Growth in biotech often occurs through the acquisition of promising startups and technologies, which can be financed with debt. This chart provides an idea of how aggressively the company uses debt to expand its product portfolio.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Bio Techne Corporation
Bio-Techne supplies reagents and tools for biotech research, where innovation is key to success. This chart illustrates the company's financial strategy in the science-intensive sector. It illustrates how Bio-Techne uses debt capital to finance its own development and the acquisition of promising companies, accelerating its growth in the life sciences market.
Market segment debt to market segment book capitalization - Diagnostic medical equipment
Bio-Techne Corporation develops and manufactures reagents and tools for biotech research. The chart shows the overall debt burden in the diagnostic equipment sector. This allows us to understand whether Bio-Techne finances its growth and acquisitions with debt more aggressively or more conservatively than the tech industry average.
Debt to book value of all companies in the market
Bio-Techne Corporation operates in the innovative biotechnology sector, where discoveries trump market cycles. This chart shows the dynamics of the overall market's leverage. This helps us understand whether Bio-Techne is funding its growth and acquisitions based on scientific breakthroughs and strategic opportunities, even as the overall market is deleveraging.
P/E of the company, segment and market as a whole
P/E - Bio Techne Corporation
For Bio-Techne Corporation, a manufacturer of reagents and instruments for biomedical research, this chart demonstrates investor confidence in the biotech sector. A high P/E is often justified by expectations of new scientific discoveries and stable demand from pharmaceutical companies. A decline may be due to reduced government funding for science or unsuccessful clinical trials.
P/E of the market segment - Diagnostic medical equipment
This chart shows the average P/E ratio for the medical diagnostics sector. For Bio-Techne, this is a key benchmark. A company's P/E above this industry level indicates the market is willing to pay a premium for its innovative products and stable demand from biotech and pharmaceutical companies.
P/E of the market as a whole
Bio-Techne Corporation supplies the scientific community with reagents and research tools, playing a vital role in biotech development. Demand for its products is less cyclical, as research is funded over the long term. This chart shows whether the market values this stability above or below average during different phases of economic cycles.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Bio Techne Corporation
Bio-Techne Corporation develops and manufactures reagents and tools for biotech research and clinical diagnostics. The company's future growth depends on research funding and success in developing new diagnostic tests. This chart reflects market expectations regarding the development of the pharmaceutical industry and Bio-Techne's ability to remain a leader in its niche.
%20P%2FE%20Bio%20Techne%20Corporation&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Bio-Techne-Corporation&v=1772513543252 "Chart of the company's future (projected) P/E Bio Techne Corporation")
Future (projected) P/E of the market segment - Diagnostic medical equipment
Bio-Techne Corporation supplies innovative reagents and tools for biotech research and clinical diagnostics. The company helps science advance. The data presented shows average profitability expectations in its sector, providing an opportunity to assess how highly the market values Bio-Techne's scientific potential and commercial prospects.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Diagnostic-medical-equipment&v=1772513543336 "Future (projected) P/E graph of the market segment - Diagnostic medical equipment")
Future (projected) P/E of the market as a whole
Bio-Techne supplies reagents and tools for biotech research. Their growth depends on funding from science and the pharmaceutical industry. General market optimism, reflected in the graph, often translates into increased R&D budgets for both large pharmaceutical companies and daring biotech startups. For Bio-Techne, this means a steady flow of orders and confidence in the future.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513543418 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Bio Techne Corporation
Bio-Techne Corporation develops and manufactures reagents and tools for biotech research. This chart shows the financial impact of the company's innovation activities. Its profits are growing thanks to consistent demand from pharmaceutical and scientific laboratories, and the successful launch of new products directly accelerates financial performance.
Profit of companies in the market segment - Diagnostic medical equipment
Bio-Techne Corporation produces reagents and tools for biotech research. The company's success depends on the level of funding for pharmaceutical research and development. This chart shows the overall profitability of the diagnostic equipment sector, which is growing as investment in personalized medicine and scientific discovery increases.
Overall market profit
Bio-Techne Corporation produces reagents and tools for biotech research and clinical diagnostics. Demand for the company's products is supported by ongoing investments in science and healthcare. This makes its business relatively resilient to economic cycles, allowing its stability to be compared with overall market volatility, as shown in the chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Bio Techne Corporation
Bio-Techne Corporation develops and manufactures reagents and tools for biotech research and clinical diagnostics. The company's expected profits depend on research funding and pharmaceutical activity. This chart shows analysts' forecasts for the growth rate of the biomedical research market and Bio-Techne's ability to maintain a leading position in it.
%20profit%20of%20the%20company%20Bio%20Techne%20Corporation&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Bio-Techne-Corporation&v=1772513543515 "Graph of future (projected) profit of the company Bio Techne Corporation")
Future (predicted) profit of companies in the market segment - Diagnostic medical equipment
Bio-Techne equips scientists and clinicians with tools for biological research and diagnostics. The company operates at the forefront of science, where innovation drives future growth. This chart displays profitability forecasts for the medical device sector. It helps assess how market expectations align with growth potential in niches such as gene therapy.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Diagnostic-medical-equipment&v=1772513543569 "Graph of future (predicted) profits of companies in a market segment - Diagnostic medical equipment")
Future (predicted) profit of the market as a whole
Bio-Techne supplies instruments and reagents for biotech research. The profit expectations shown in this chart indirectly reflect the willingness of governments and corporations to invest in science and healthcare. Increased overall economic forecasts often correlate with increased R&D funding, creating a favorable environment for the growth of a company whose products are indispensable in laboratories.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513543615 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Bio Techne Corporation
Bio-Techne Corporation develops and manufactures reagents and tools for biotech research and clinical diagnostics. Its revenue estimate, presented in the chart, reflects investor confidence in the long-term growth of the life sciences sector. The dynamics of this indicator indicate the market's confidence in future revenue from innovations in medicine and biology.
P/S market segment - Diagnostic medical equipment
Bio-Techne Corporation manufactures and markets reagents, instruments, and services for biomedical research and clinical diagnostics. The company's products are used by scientists to study biological processes and develop new treatments. This chart shows the average rating for the sector, helping to understand how the market values Bio-Techne's contributions to scientific research.
P/S of the market as a whole
Bio-Techne Corporation develops and manufactures reagents and tools for biotech research. The company is a key supplier to the scientific and pharmaceutical industries. How highly does the market value revenue in the innovative biology sector? This chart provides a broad overview of the market, helping to assess Bio-Techne's revenue in a broader context.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Bio Techne Corporation
Bio-Techne Corporation produces and sells reagents and tools for biotech research and clinical diagnostics. This chart reflects investor sentiment regarding the company's future sales. This trend is driven by forecasts for R&D spending in the pharmaceutical and biotech industries, which are key drivers of demand for Bio-Techne's products.
%20P%2FS%20Bio%20Techne%20Corporation&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Bio-Techne-Corporation&v=1772513543685 "The graph of the company's future (projected) P/S Bio Techne Corporation")
Future (projected) P/S of the market segment - Diagnostic medical equipment
Bio-Techne Corporation supplies the scientific community with tools and reagents for biotech research. This chart compares the company's future revenue expectations with industry peers. It helps assess the market's confidence in Bio-Techne's ability to grow faster than competitors through innovation and demand from the pharmaceutical industry.
%20P%2FS%20market%20segment%20graph%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Diagnostic-medical-equipment&v=1772513543740 "Future (projected) P/S market segment graph - Diagnostic medical equipment")
Future (projected) P/S of the market as a whole
Investor optimism about future revenues is often based on breakthroughs in science and medicine. Bio-Techne, a supplier of reagents and tools for biotech research, is at the center of these innovations. Demand for its products reflects the market's belief that scientific discoveries will lead to new drugs and diagnostics, stimulating growth for the entire industry.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513543759 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Bio Techne Corporation
Bio-Techne Corporation is a key supplier of reagents and instruments for biomedical research and clinical diagnostics. The company's revenue is generated through sales of a wide range of products to scientific laboratories and biotechnology companies. This chart illustrates how investments in science and healthcare translate into the company's cash flows.
Sales of companies in the market segment - Diagnostic medical equipment
Bio-Techne Corporation supplies innovative reagents, tools, and proteins for biomedical research and clinical diagnostics. The company helps scientists make new discoveries. This chart shows the total revenue of the diagnostic equipment segment. It demonstrates the size and dynamics of the global investments in science and medicine that fuel Bio-Techne's growth.
Overall market sales
Bio-Techne Corporation develops and produces reagents, tools, and proteins for biotech research and clinical diagnostics. The company's clients include scientific laboratories and pharmaceutical giants. Demand for its products depends on funding for science and medicine. This graph of overall economic activity indirectly reflects R&D and healthcare budgets.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Bio Techne Corporation
Bio-Techne Corporation produces reagents and tools for biotech research and medical diagnostics. Its success is driven by investments in science and healthcare. This chart represents analysts' consolidated revenue forecasts, illustrating their expectations for pharmaceutical R&D funding and diagnostic testing market growth.
%20sales%20of%20the%20company%20Bio%20Techne%20Corporation&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Bio-Techne-Corporation&v=1772513543945 "Schedule of future (projected) sales of the company Bio Techne Corporation")
Future (projected) sales of companies in the market segment - Diagnostic medical equipment
Bio-Techne Corporation develops and manufactures reagents and instruments for biomedical research and clinical diagnostics. The company's success is linked to the level of scientific funding and the development of biotechnology. This chart shows projected sales for the entire diagnostic equipment sector, reflecting analyst expectations regarding investment in healthcare and scientific research.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Diagnostic-medical-equipment&v=1772513543980 "Schedule of future (projected) sales of companies in the market segment - Diagnostic medical equipment")
Future (projected) sales of the market as a whole
Bio-Techne Corporation produces reagents and tools for biotech research and diagnostics. The company's growth is fueled by investments in scientific research and healthcare. This revenue projection chart reflects the economic capacity of governments and the private sector to fund R&D, a key driver of demand for Bio-Techne's products.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513544018 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Bio Techne Corporation
Bio-Techne supplies reagents and instruments for biomedical research, and its success depends on innovation. This metric reflects the financial return on these innovations, demonstrating what percentage of the company's revenue is converted into profit. This demonstrates the efficiency of R&D, production, and pricing power in the specialized scientific market.
Market segment marginality - Diagnostic medical equipment
Bio-Techne produces reagents and instruments for biomedical research, serving as a vital link in the drug discovery chain. It values not only innovation but also efficiency. The data in the chart demonstrates how the company manages its production and sales compared to other players, reflecting the strength of its product portfolio and operational discipline.
Market marginality as a whole
Bio-Techne Corporation supplies reagents and tools for biomedical research, serving as a vital link in the scientific discovery chain. This graph shows the average economic return, which for Bio-Techne reflects the level of R&D funding. When corporations and governments are confident about the future, they invest more in science, increasing demand for the company's products.
Employees in the company, segment and market as a whole
Number of employees in the company Bio Techne Corporation
Bio-Techne Corporation is a supplier of reagents and tools for biotech research and diagnostics. Human resources here translate into scientific potential. This chart illustrates how the company is expanding its research and manufacturing teams to develop new tests, antibodies, and proteins, accelerating medical discoveries worldwide.
Share of the company's employees Bio Techne Corporation within the market segment - Diagnostic medical equipment
Bio-Techne Corporation supplies the scientific community with research tools. This chart shows the percentage of scientists, engineers, and technicians in the biomedical diagnostics sector the company employs. Its human capital drives innovation, accelerating the development of new drugs and treatments.
Number of employees in the market segment - Diagnostic medical equipment
Bio-Techne Corporation creates and supplies reagents and instruments for biotech research and clinical diagnostics. This chart shows the total number of people employed in the diagnostic medical equipment sector. For Bio-Techne, this growth signals the expansion of scientific research and increased laboratory budgets, which directly drives demand.
Number of employees in the market as a whole
Bio-Techne Corporation is a supplier of reagents and tools for biotech research. This chart illustrates the company's strategy to expand its scientific capabilities. The growth of its staff, particularly its research staff, reflects its investment in the development of new diagnostic tests and therapeutic proteins, strengthening its position at the forefront of life sciences.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Bio Techne Corporation (TECH)
Bio-Techne Corporation produces reagents and tools for biotech research. This graph reflects the high market valuation of the company's intellectual property. Every employee, from scientists to production specialists, contributes to the creation of unique, patent-protected products, resulting in high added value per employee.
%20of%20the%20company%20Bio%20Techne%20Corporation%20(TECH)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Bio-Techne-Corporation-TECH&v=1772513544270 "Chart of market capitalization per employee (in thousands of dollars) of the company Bio Techne Corporation (TECH)")
Market capitalization per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
Bio-Techne supplies reagents, proteins, and tools for biomedical research. It is an R&D-intensive business where value is created through intellectual property and a broad product portfolio. This metric, compared to the industry average, reflects how highly the market values the company's scientific potential and product portfolio per employee.
%20by%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Diagnostic-medical-equipment&v=1772513544276 "Market capitalization per employee (in thousands of dollars) by market segment - Diagnostic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Bio-Techne Corporation develops and manufactures reagents and tools for biotech research. It is a knowledge-intensive business, where scientists and researchers play a key role. The indicator presented here demonstrates a high assessment of intellectual capital: each employee makes a significant contribution to the creation of unique products for the pharmaceutical and scientific industries.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513544279 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Bio Techne Corporation (TECH)
Bio-Techne Corporation supplies reagents, tools, and proteins for biotech research and clinical diagnostics. It's a knowledge-intensive business where value is created by scientists and researchers. This chart shows the economic efficiency of their R&D, measuring how scientific discoveries and patents are converted into net profit per employee.
%20Chart%20Bio%20Techne%20Corporation%20(TECH)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Bio-Techne-Corporation-TECH&v=1772513544290 "Company Profit Per Employee (in thousands of dollars) Chart Bio Techne Corporation (TECH)")
Profit per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
Bio-Tech is a "supplier" for science. They produce consumables (proteins, antibodies) and tools for biotech R&D. This graph shows the benchmark for "Diagnostic Medical Equipment." This industry has high labor margins. It's a "razor and blades" model: the sector sells consumables (blades) for research.
%20in%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Diagnostic-medical-equipment&v=1772513544330 "Chart of profit per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Bio-Techne (TECH) develops and produces high-quality reagents, proteins, and diagnostic tools for biotech research and clinical diagnostics. This chart, showing average earnings per employee across the market, provides context. It helps understand how the life sciences sector, which relies on scientists and researchers, is highly profitable in terms of human capital.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513544345 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Bio Techne Corporation (TECH)
At Bio-Techne, a manufacturer of reagents and instruments for biomedical research, this chart reflects the value of intellectual capital. The growth of this indicator demonstrates the high demand for the company's unique products and the effectiveness of its R&D team, which creates sought-after scientific solutions for global laboratories.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Bio-Techne-Corporation-TECH&v=1772513544381 "Sales chart per company employee Bio Techne Corporation (TECH)")
Sales per employee in the market segment - Diagnostic medical equipment
Bio-Techne creates and sells instruments and reagents for biotech research. Success here depends on its R&D and sales teams. This graph shows the average revenue per employee in their segment. Comparing this value helps us understand how effectively Bio-Techne monetizes its research and development efforts using its own staff compared to other life sciences companies.
Sales per employee for the market as a whole
Bio-Techne (TECH) produces critical reagents and diagnostic equipment for biotech research. This metric reflects how successfully the company is scaling its portfolio. High values indicate that their unique reagents (consumables) generate significant revenue, while their R&D and manufacturing staff are growing more slowly.
Short shares by company, segment and market as a whole
Shares shorted by company Bio Techne Corporation (TECH)
Bio-Techne Corporation produces high-tech reagents, proteins, and diagnostic tools used in biotech research and drug development. The company's success depends on global R&D budgets. This chart reflects how many investors are betting on a possible reduction in biotech funding, which will slow the procurement of research tools.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Bio-Techne-Corporation-TECH&v=1772513544421 "Short Shares Chart for the Company Bio Techne Corporation (TECH)")
Shares shorted by market segment - Diagnostic medical equipment
Bio-Techne (TECH) produces high-quality reagents and tools for biotech research and clinical diagnostics. They are the "shovel suppliers" for the pharmaceutical industry. This chart shows the total short position in the medical equipment sector. It reflects market concerns about the level of R&D funding in biotech and the spending on diagnostics.
Shares shorted by the overall market
Bio-Techne Corporation supplies reagents and tools for biotech research. The company relies on R&D budgets from the pharmaceutical industry. This chart illustrates the general fear in the market. When it rises, investors may fear that even biotech companies will begin to cut research spending in anticipation of a recession, which will slow Bio-Techne's growth.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Bio Techne Corporation (TECH)
Bio-Techne supplies reagents and instruments for biomedical research. The business relies on R&D budgets in the pharmaceutical and biotech industries. A TECH score above 70 may reflect strong demand from R&D. A score below 30 may signal concerns about R&D budget cuts (a "venture winter").
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Bio-Techne-Corporation-TECH&v=1772513544519 "RSI 14 indicator chart for the company's stock Bio Techne Corporation (TECH)")
RSI 14 Market Segment - Diagnostic medical equipment
Bio-Techne Corporation supplies tools and reagents for biotech research and clinical diagnostics. Their products (proteins and antibodies) are used by scientists to study diseases. This chart measures the overall momentum in the life sciences sector. It helps understand whether the entire segment is oversold following the pandemic or amid cuts in R&D budgets.
RSI 14 for the overall market
Bio-Techne produces reagents and instruments for biotech research and diagnostics. These are "consumables" for science. Demand for them is less volatile than the market itself. This indicator helps assess the context: even during periods of market panic (overselling), labs continue to order reagents, making TECH relatively stable.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast TECH (Bio Techne Corporation)
Bio-Techne is a "picks and shovels" supplier to the biotech industry. They produce critical reagents (proteins, antibodies) and tools used in R&D and diagnostics. This chart is a collective 12-month forecast from analysts. It reflects their expectations for R&D budgets in the pharmaceutical and biotech industries.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-TECH-Bio-Techne-Corporation&v=1772513544627 "A chart showing analyst consensus forecasts for the expected stock price. TECH (Bio Techne Corporation)")
The difference between the consensus estimate and the actual stock price TECH (Bio Techne Corporation)
Bio-Techne (TECH) is a supplier of life science consumables. They produce proteins, antibodies, and diagnostic tools used in biotech research. This chart shows their R&D valuation. It measures the gap between the price and the consensus target, reflecting the potential analysts see in growing pharmaceutical research spending.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-TECH-Bio-Techne-Corporation&v=1772513544631 "A chart showing the difference between the consensus forecast and the actual stock price. TECH (Bio Techne Corporation)")
Analyst consensus forecast for stock prices by market segment - Diagnostic medical equipment
Bio-Techne is a key player in the biotech gold rush. The company supplies reagents (proteins, antibodies) and laboratory instruments needed for pharmaceutical R&D. This chart shows analysts' general expectations for the biotech and diagnostics sector. It reflects whether experts believe R&D spending will increase or decline.
Analysts' consensus forecast for the overall market share price
Bio-Techne (TECH) is a laboratory giant that supplies consumables (reagents, proteins) and instruments to biotech R&D labs and academia. Market expectations, visible on this chart, influence their clients. If the market is pessimistic, risk appetite declines, biotech companies receive less funding and cut R&D budgets.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Bio Techne Corporation
Bio-Techne is a supplier to the life sciences industry. They produce high-quality reagents, proteins, and tools used in biotech and pharmaceutical R&D labs. This chart is an indicator of research expenditures. Its steady growth reflects the strength of their products, which are integral to the drug discovery process.
AKIMA Market Segment Index - Diagnostic medical equipment
Bio-Techne is a premium supplier of consumables (proteins, antibodies, reagents) for R&D laboratories in the pharmaceutical and biotech industries. This aggregate metric evaluates companies. The chart shows the sector average. This benchmark: to what extent does Bio-Techne's indispensable role in scientific discovery and its cutting-edge model distinguish it from the average competitor?
The AKIM Index for the overall market
Bio-Techne is the pickaxe and shovels of biotech. The company supplies reagents and analytical instruments essential for R&D in the pharmaceutical industry. This chart, reflecting the market average, is a backdrop. It helps assess how this defense business, dependent on R&D budgets (which are not cyclical), stacks up against the backdrop of general macroeconomic fluctuations.
